Company intelligence / Profile preview

Omnyx

Pittsburgh, Pennsylvania, United Statesprnewswire.com ↗

Ownership: Private
Development stage: Commercial

Overview

Omnyx developed integrated digital pathology solutions, including high-speed whole-slide scanners and enterprise software to digitize, manage, and analyze pathological slides. Their flagship product Dynamyx™ was CE-marked in Europe and licensed by Health Canada for clinical use. In the US, some products were cleared by the FDA for specific applications such as HER2 analysis. The company aimed to improve efficiency, collaboration, and accuracy in cancer diagnosis through digital transformation of traditional workflows.

Therapeutic areas: Oncology
Modalities: DeviceSoftware (Digital pathology workflow)
Industry: Pathology

Partnerships

GE Healthcare (joint venture partner/founder)UPMC – University of Pittsburgh Medical Center (joint venture partner/founder)Inspirata (acquirer/partner post-acquisition)

Beyond the preview

Go deeper on Omnyx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omnyx.

Explore the full profile